CVM GFI #290 (VICH GL61) – Pharmaceutical Development
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 6, 2024
May 3, 2024
e8fd92df-cd71-4f54-be38-a00b312eecbb
Related Documents
CVM GFI #285 - Manufacture of Batches in Support of Original NADAs, ANADAs, and CNADAs
Guidance DocumentMarch 18, 2024Center for Veterinary Medicine
CVM GFI #286 (VICH GL60) - Good Manufacturing Practice for Active Pharmaceutical Ingredients Used in Veterinary Medicinal Products
Guidance DocumentJanuary 25, 2024Center for Veterinary Medicine
CVM GFI #264 Standardized Medicated Feed Assay Limits
Guidance DocumentFebruary 27, 2020Center for Veterinary Medicine
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox